Table 2.
No | IVCT | Trigger agents | Masseterspasm | Dantrolene application | Cardiac arrhythmia | Max. end-tidal CO2[mmHg] | Max. temperature | Max. Creatine kinase [U/L] |
---|---|---|---|---|---|---|---|---|
1 |
MHS |
Isoflurane + SCh |
Unknown |
1 × 200 mg |
Sinus tachycardia |
48 mmHg |
38.8°C |
10.514 |
2 |
MHS |
Isoflurane + SCh |
Yes |
1 × 240 mg |
Tachyarrhythmia |
54 mmHg |
36.1°C |
> 10.000 |
3 |
MHS |
Sevoflurane + SCh |
Yes |
No |
Sinus tachycardia |
Unknown |
Unknown |
51.557 |
4 |
MHS |
Sevoflurane + SCh |
Unknown |
2 × 200 mg |
Sinus tachycardia |
62 mmHg |
Unknown |
23.700 |
5 |
MHS |
Desflurane + SCh |
Unknown |
1 × 220 mg |
Tachyarrhythmia |
56 mmHg |
37.6°C |
≈ 80.000 |
6 |
MHS |
Sevoflurane |
No |
1 × 200 mg |
No |
85 mmHg |
37.5°C |
38.762 |
7 |
MHS |
Isoflurane + SCh |
Unknown |
No |
Unknown |
Unknown |
Unknown |
16.412 |
8 |
MHEh |
SCh |
Yes |
1 × 200 mg |
Unknown |
39 mmHg |
Unknown |
119.150 |
9 |
MHEh |
SCh |
Yes |
Unknown |
No |
36 mmHg |
Unknown |
162 |
10 |
MHEh |
SCh |
Yes |
No |
Unknown |
Unknown |
Unknown |
2.234 |
11 |
MHEh |
Halothane + SCh |
Yes |
Unknown |
Tachyarrhythmia |
Unknown |
Unknown |
Low |
12 |
MHN |
SCh |
Yes |
No |
Tachyarrhythmia |
Unknown |
Unknown |
132 |
13 |
MHN |
Isoflurane |
Yes |
No |
Unknown |
54 mmHg |
Unknown |
4.100 |
14 |
MHN |
SCh |
Yes |
No |
Unknown |
Unknown |
Unknown |
24.732 |
15 |
MHN |
Desflurane |
No |
1 × 180 mg |
Tachyarrhythmia |
72 mmHg |
Unknown |
Unknown |
16 |
MHN |
SCh |
Yes |
No |
Unknown |
Unknown |
Unknown |
Unknown |
17 |
MHN |
Desflurane |
No |
No |
Unknown |
Unknown |
38,5°C |
Unknown |
18 |
MHN |
Isoflurane + SCh |
Yes |
No |
Unknown |
41 mmHg |
Unknown |
5.174 |
19 | MHN | Enflurane + SCh | Yes | No | Unknown | 75 mmHg | Unknown | 4.820 |
IVCT In vitro contracture test, MHS Malignant hyperthermia susceptible, MHN malignant hyperthermia non-susceptible, MHEh Malignant hyperthermia equivocal to halothane, SCh Succinylcholine, CO2 Carbon dioxide.